Orion Health hopes to achieve profitability in the 2018 financial year as revenue continues to grow and its large investment in research and development for its Amadeus precision medicine platform begins to level off.

Announcing its first half results for the 2017 financial year, Orion Health CEO Ian McCrae said the company had operating revenue of $NZ104 million, with $25m coming from the Asia Pacific region.